Summary
Lord's Mark Industries is undertaking a strategic healthcare expansion and business demerger, focusing on advanced diagnostics, oncology, and medical devices, including CAR-T cell therapy. The company also plans international subsidiaries in the UK and Switzerland, targeting ₹1,550 Crore revenue by FY2027.